Summary & Overview
Single Level Spinal Fusion Except Cervical without MCC: Inpatient Reimbursement Overview
DRG 451 encompasses single level spinal fusion procedures outside the cervical spine without a Major Complication or Comorbidity; it addresses resource use for single-segment lumbar or thoracolumbar fusions. Proper classification into this Diagnosis-Related Group matters for inpatient reimbursement because the assigned Diagnosis-Related Group determines the Medicare prospective payment for the hospital stay.
DRG 451 Overview
DRG 451 covers single level spinal fusion procedures outside the cervical region without a Major Complication or Comorbidity and is commonly assigned for lumbar or thoracolumbar fusion at one motion segment. This Diagnosis-Related Group captures cases where the primary surgical intervention is a single-level posterior, anterior, or combined approach spinal fusion without high-severity comorbid conditions. It matters for Medicare payment because the Diagnosis-Related Group assignment drives the inpatient prospective payment amount, influencing hospital reimbursement for resource use associated with operative time, implants, and postoperative care. Accurate coding of diagnoses and procedures determines whether a case is grouped to DRG 451 versus other fusion-related or higher-severity Diagnosis-Related Groups.
Clinical Trials
- Perioperative pain management and opioid-sparing protocols: trials evaluate multimodal analgesia regimens, regional anesthesia techniques (such as erector spinae plane or paraspinal blocks), and non-opioid adjuncts in adults undergoing single-level lumbar or thoracic fusion without major complications. The patient population includes primarily middle-aged to older adults with degenerative disc disease, spondylolisthesis, or spinal stenosis scheduled for elective single-level fusion, focusing on intraoperative and immediate postoperative pain, opioid consumption, and early mobilization. This research is relevant to providers for optimizing perioperative care pathways and reducing complications, and to payers because effective protocols can shorten length of stay, lower opioid-related adverse events, and reduce readmission risk, all impacting costs for this DRG.
- Comparative effectiveness of surgical approaches and intraoperative technology for single-level non-cervical fusion: randomized or prospective cohort studies compare surgical techniques (eg, minimally invasive posterior lumbar interbody fusion versus open fusion), implant strategies, or use of navigation/neuromonitoring to assess fusion rates, operative time, blood loss, and complication profiles. Studies enroll patients indicated for a single-level fusion without major comorbid complications and examine mid-term outcomes such as reoperation rates and functional scores at 6–24 months. This area informs surgeons and hospitals about which approaches deliver better clinical outcomes and resource use for this specific DRG population, helping payers evaluate value and reimbursement policies tied to procedure selection and device utilization.
- Post-discharge recovery, rehabilitation, and health-economic outcomes: observational studies and pragmatic trials assess outpatient rehabilitation intensity, home-based physical therapy, remote monitoring, and care-coordination interventions to improve functional recovery, return-to-work, and reduce post-acute utilization among patients discharged after single-level spinal fusion. The population includes patients transitioning from inpatient to outpatient care, often with variable social support and comorbidities influencing recovery; outcomes measured include readmissions, emergency visits, patient-reported outcomes, and total episode-of-care costs over 90 days to one year. These studies are critical for providers and payers because optimizing post-discharge pathways can lower downstream costs, decrease avoidable readmissions, and improve long-term functional outcomes for patients classified under this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.